Target intelligence / Profile preview

MT-ND1 pseudogene 9 (MTND1P9)

Target
MTND1P9
Molecular classification
Pseudogene
01

Overview

MT-ND1 pseudogene 9 (MTND1P9) is a genomic DNA region classified as a pseudogene based on annotation and sequence analysis[2][6]. It is similar in sequence to the *MT-ND1* gene, which encodes the NADH-ubiquinone oxidoreductase chain 1, a key subunit of Complex I of the mitochondrial electron transport chain[1][3][5]. However, as a pseudogene, *MTND1P9* does not produce a functional protein product and has not been demonstrated to have any direct biological function[2][6]. It has no therapeutic relevance, and is not a receptor, enzyme, or other druggable target. No disease associations, drug interactions, or biomarker roles are described for this pseudogene, and it is not considered a therapeutic target. If your intent was to reference a functional mitochondrial gene—and not a pseudogene—then *MT-ND1* (not *MTND1P9*) is the functional gene encoding NADH-ubiquinone oxidoreductase chain 1[1][3][5]. If *MTND1P9* was provided as a target with the expectation of therapeutic targeting, this is incorrect: it is a nonfunctional pseudogene[2][6]. Key clarifications: - *MTND1P9* is a pseudogene, not an active protein-coding gene or therapeutic target. - No current evidence supports any therapeutic, functional, or biomarker role for *MTND1P9*[2][6]. - The functional cognate gene is *MT-ND1*, not *MTND1P9*[1][3][4][5].

Other names
MT-ND1 pseudogene 9MTND1P9

Beyond the preview

Go deeper on MT-ND1 pseudogene 9 (MTND1P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND1 pseudogene 9 (MTND1P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call